These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 29691588)

  • 1. Serum Carcinoembryonic Antigen Level as a Marker for Advanced Stage and Chemotherapeutic Response in Extramammary Paget's Disease.
    Umemura H; Yamasaki O; Kaji T; Otsuka M; Asagoe K; Iwatsuki K
    Acta Derm Venereol; 2018 Jul; 98(7):706-707. PubMed ID: 29691588
    [No Abstract]   [Full Text] [Related]  

  • 2. Trial of low-dose 5-fluorouracil/cisplatin therapy for advanced extramammary Paget's disease.
    Kariya K; Tsuji T; Schwartz RA
    Dermatol Surg; 2004 Feb; 30(2 Pt 2):341-4. PubMed ID: 14871231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring serum cytokeratin 19 fragment 21-1 to determine the efficacy of docetaxel chemotherapy in advanced extramammary Paget's disease.
    Onishi M; Maeda F; Akasaka T; Amano H
    J Dermatol; 2019 Mar; 46(3):e83-e84. PubMed ID: 30194782
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful TS-1 monotherapy as the second-line treatment for advanced extramammary Paget's disease: A report of two cases.
    Kato J; Hida T; Yamashita T; Kamiya S; Horimoto K; Sato S; Takahashi H; Sawada M; Yamada M; Uhara H
    J Dermatol; 2018 Jan; 45(1):80-82. PubMed ID: 28891079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of sentinel lymph node biopsy for the detection of metastasis in the early stage of extramammary Paget's disease.
    Kusatake K; Harada Y; Mizumoto K; Kaneko S; Niihara H; Chinuki Y; Morita E
    Eur J Dermatol; 2015 Apr; 25(2):156-61. PubMed ID: 26075323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen-receptor-alpha-positive extramammary Paget's disease treated with hormonal therapy.
    Iijima M; Uhara H; Ide Y; Sakai S; Onuma H; Muto M; Hayashi K; Mitsura F; Kobayashi S; Yoshizawa A; Saida T
    Dermatology; 2006; 213(2):144-6. PubMed ID: 16902292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor thickness as a prognostic factor in extramammary Paget's disease.
    Ito T; Kaku Y; Nagae K; Nakano-Nakamura M; Nakahara T; Oda Y; Hagihara A; Furue M; Uchi H
    J Dermatol; 2015 Mar; 42(3):269-75. PubMed ID: 25557434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cytokeratin 19 fragment 21-1 is a useful tumor marker for the assessment of extramammary Paget's disease.
    Kato J; Sumikawa Y; Hida T; Kamiya T; Horimoto K; Kamiya S; Sato S; Takahashi H; Sawada M; Yamashita T
    J Dermatol; 2017 Jun; 44(6):666-670. PubMed ID: 28150330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic extramammary Paget's disease successfully controlled with tumour dormancy therapy using docetaxel.
    Fujisawa Y; Umebayashi Y; Otsuka F
    Br J Dermatol; 2006 Feb; 154(2):375-6. PubMed ID: 16433815
    [No Abstract]   [Full Text] [Related]  

  • 10. A proposal for a TNM staging system for extramammary Paget disease: Retrospective analysis of 301 patients with invasive primary tumors.
    Ohara K; Fujisawa Y; Yoshino K; Kiyohara Y; Kadono T; Murata Y; Uhara H; Hatta N; Uchi H; Matsushita S; Takenouchi T; Hayashi T; Yoshimura K; Fujimoto M
    J Dermatol Sci; 2016 Sep; 83(3):234-9. PubMed ID: 27329007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential use with imiquimod and surgery in extramammary Paget's disease.
    Toledo F; Silvestre JF; Cuesta L; Ballester I; Latorre N; Monteagudo A
    Dermatol Ther; 2012; 25(1):82-5. PubMed ID: 22591501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum carcinoembryonic antigen level in Paget's disease.
    Oji M; Furue M; Tamaki K
    Br J Dermatol; 1984 Feb; 110(2):211-3. PubMed ID: 6320860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node biopsy in patients with extramammary Paget's disease.
    Hatta N; Morita R; Yamada M; Echigo T; Hirano T; Takehara K; Ichiyanagi K; Yokoyama K
    Dermatol Surg; 2004 Oct; 30(10):1329-34. PubMed ID: 15458530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical demonstration of epithelial membrane antigen (EMA), carcinoembryonic antigen (CEA), and keratin on mammary and extramammary Paget's disease.
    Mori O; Hachisuka H; Sasai Y
    Acta Histochem; 1989; 85(1):93-100. PubMed ID: 2469278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose 5-fluorouracil/cisplatin therapy as conversion chemotherapy for advanced extramammary Paget's disease.
    Nakamura K; Nakamura M; Kato H; Morita A
    Kaohsiung J Med Sci; 2020 Apr; 36(4):287-288. PubMed ID: 31868989
    [No Abstract]   [Full Text] [Related]  

  • 16. CDX2 expression in cutaneous metastatic carcinomas and extramammary Paget's Disease.
    Lora V; Kanitakis J
    Anticancer Res; 2009 Dec; 29(12):5033-7. PubMed ID: 20044613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carcinoembryonic antigen in genital Paget's disease].
    Oji M; Furue M; Tamaki K
    Nihon Hifuka Gakkai Zasshi; 1985 Oct; 95(11):1135-44. PubMed ID: 3005721
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of metastatic extramammary Paget's disease with S-1 and docetaxel combination chemotherapy.
    Matsushita S; Yonekura K; Mera K; Kawai K; Kanekura T
    J Dermatol; 2011 Oct; 38(10):996-8. PubMed ID: 21972953
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinicopathological characteristics, management and outcome of metastatic penoscrotal extramammary Paget's disease.
    Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ; Mao HR
    Br J Dermatol; 2009 Sep; 161(3):577-82. PubMed ID: 19438449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable patterns of positron emission tomography in the assessment of patients with extramammary Paget's disease.
    Cho SB; Yun M; Lee MG; Chung KY
    J Am Acad Dermatol; 2005 Feb; 52(2):353-5. PubMed ID: 15692486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.